Sum Lam

486 total citations
28 papers, 353 citations indexed

About

Sum Lam is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Sum Lam has authored 28 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Sum Lam's work include Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Sum Lam is often cited by papers focused on Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Sum Lam collaborates with scholars based in United States, Taiwan and Hong Kong. Sum Lam's co-authors include Irving H. Gomolin, Olga Hilas, Tomasz Z. Jodlowski, Priti N. Patel, Sharon See, Christine M. Ruby, Tran H. Tran, Kathryn Choon Beng Tan, Melissa Fazzari and Ying Wong and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Annals of Pharmacotherapy and American Journal of Health-System Pharmacy.

In The Last Decade

Sum Lam

28 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sum Lam United States 11 88 64 64 50 45 28 353
Pipasha Biswas United Kingdom 10 98 1.1× 37 0.6× 44 0.7× 63 1.3× 60 1.3× 15 528
William Wang United States 10 107 1.2× 76 1.2× 178 2.8× 21 0.4× 38 0.8× 19 460
Kenneth D. Katz United States 14 34 0.4× 80 1.3× 62 1.0× 31 0.6× 43 1.0× 54 530
Bharti Chogtu India 12 34 0.4× 49 0.8× 46 0.7× 24 0.5× 18 0.4× 62 375
Anhye Kim South Korea 9 28 0.3× 69 1.1× 29 0.5× 26 0.5× 33 0.7× 40 328
Supriya Malhotra India 10 45 0.5× 33 0.5× 51 0.8× 35 0.7× 29 0.6× 65 469
Bernardino Barceló Martín Spain 12 80 0.9× 67 1.0× 61 1.0× 8 0.2× 35 0.8× 66 787
Engi Algharably Germany 11 43 0.5× 36 0.6× 25 0.4× 29 0.6× 109 2.4× 26 546
Mireille Gris Belgium 5 34 0.4× 43 0.7× 34 0.5× 99 2.0× 28 0.6× 7 342
Enrico Silingardi Italy 10 52 0.6× 58 0.9× 135 2.1× 13 0.3× 73 1.6× 29 387

Countries citing papers authored by Sum Lam

Since Specialization
Citations

This map shows the geographic impact of Sum Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sum Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sum Lam more than expected).

Fields of papers citing papers by Sum Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sum Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sum Lam. The network helps show where Sum Lam may publish in the future.

Co-authorship network of co-authors of Sum Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Sum Lam. A scholar is included among the top collaborators of Sum Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sum Lam. Sum Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Sum, et al.. (2022). Effect of type 2 diabetes on A disintegrin and metalloprotease 10. Journal of Diabetes. 14(6). 394–400. 8 indexed citations
2.
Pinkhasov, Aaron, et al.. (2021). Effect of Low Dose Haloperidol and Quetiapine on QTc Interval in Hospitalized Elderly Patients With Delirium. Journal of Pharmacy Practice. 34(5). 675–677. 2 indexed citations
3.
Pinkhasov, Aaron, et al.. (2017). Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting. Clinical Drug Investigation. 37(12). 1137–1141. 6 indexed citations
4.
Lam, Sum, et al.. (2015). Omega-3-Carboxylic Acid (Epanova) for Hypertriglyceridemia. Cardiology in Review. 23(3). 148–152. 1 indexed citations
5.
Lam, Sum & Tran H. Tran. (2015). Vorapaxar. Cardiology in Review. 23(5). 261–267. 7 indexed citations
6.
Lam, Sum. (2013). Apixaban. Cardiology in Review. 21(4). 207–212. 1 indexed citations
7.
Lam, Sum. (2012). Linezolid-Associated Thrombocytopenia. The Consultant Pharmacist. 27(7). 504–508. 5 indexed citations
8.
Lam, Sum. (2011). Azilsartan. Cardiology in Review. 19(6). 300–304. 18 indexed citations
9.
Lam, Sum, et al.. (2010). Saxagliptin. Cardiology in Review. 18(4). 213–217. 5 indexed citations
10.
Lam, Sum & Tomasz Z. Jodlowski. (2009). <b>Vaccines for Older Adults</b>. The Consultant Pharmacist. 24(5). 380–391. 7 indexed citations
11.
Lam, Sum, et al.. (2009). Rivaroxaban. Cardiology in Review. 17(4). 192–197. 13 indexed citations
12.
Lam, Sum, et al.. (2008). Interferon-β1bfor the treatment of multiple sclerosis. Expert Opinion on Drug Metabolism & Toxicology. 4(8). 1111–1117. 4 indexed citations
13.
Lam, Sum, et al.. (2008). <b>Strontium Ranelate for the Management of Osteoporosis</b>. The Consultant Pharmacist. 23(7). 531–537. 2 indexed citations
14.
Lam, Sum, et al.. (2007). Sitagliptin. Cardiology in Review. 15(5). 264–271. 43 indexed citations
15.
Lam, Sum & Priti N. Patel. (2007). Varenicline: A Selective α4β2 Nicotinic Acetylcholine Receptor Partial Agonist Approved for Smoking Cessation. Cardiology in Review. 15(3). 154–161. 21 indexed citations
16.
Lam, Sum, et al.. (2007). Aliskiren. Cardiology in Review. 15(6). 316–323. 14 indexed citations
17.
Lam, Sum & Olga Hilas. (2007). Pharmacologic management of overactive bladder.. PubMed. 2(3). 337–45. 21 indexed citations
18.
Lam, Sum & Sharon See. (2006). Exenatide. Cardiology in Review. 14(4). 205–211. 19 indexed citations
19.
Lam, Sum & Irving H. Gomolin. (2006). Cefepime Neurotoxicity: Case Report, Pharmacokinetic Considerations, and Literature Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(8). 1169–1174. 72 indexed citations
20.
Lam, Sum. (2003). Insulin Glargine. PubMed. 5(3). 231–240. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pipasha Biswas Breakdown of academic impact, for papers by William Wang Breakdown of academic impact, for papers by Kenneth D. Katz Breakdown of academic impact, for papers by Bharti Chogtu Breakdown of academic impact, for papers by Anhye Kim Breakdown of academic impact, for papers by Supriya Malhotra Breakdown of academic impact, for papers by Bernardino Barceló Martín Breakdown of academic impact, for papers by Engi Algharably Breakdown of academic impact, for papers by Mireille Gris Breakdown of academic impact, for papers by Enrico Silingardi
Rankless by CCL
2026